Published in Cancer Weekly, February 2nd, 2010
Currently, cancer sufferers who are non-responsive to chemotherapy and radiation therapy have limited therapeutic options. Treatments are aggressive and associated with 'side effects' which may be as detrimental as the disease.
"We have discovered and patented a revolutionary new class of anti-cancer agents that may eliminate the need for these approaches and change the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.